Suppr超能文献

接受减肥手术的非糖尿病和非高血压个体的患病率及特征:关于代谢健康肥胖的经验教训

Prevalence and characteristics of individuals without diabetes and hypertension who underwent bariatric surgery: lessons learned about metabolically healthy obese.

作者信息

Lee Clare J, Clark Jeanne M, Asamoah Vivian, Schweitzer Michael, Magnuson Thomas, Lazo Mariana

机构信息

Division of Endocrinology, Diabetes and Metabolism, The Johns Hopkins University, Baltimore, Maryland.

Welch Center for Prevention, Epidemiology, and Clinical Research, The Johns Hopkins University, Baltimore, Maryland; Department of Medicine, Division of General Internal Medicine, The Johns Hopkins University, Baltimore, Maryland.

出版信息

Surg Obes Relat Dis. 2015 Jan-Feb;11(1):142-6. doi: 10.1016/j.soard.2014.06.012. Epub 2014 Jun 19.

Abstract

BACKGROUND

Recent studies describe a unique subset of obese individuals with normal metabolic profiles despite having excess weight called "metabolically healthy but obese (MHO)". Our aim was to determine the prevalence of individuals without diabetes and hypertension and risk factors associated with the MHO phenotype among bariatric surgery patients.

METHODS

We conducted a retrospective study of 710 adults who underwent bariatric surgery at Johns Hopkins between 2008 and 2010. In the first analysis of 523 individuals, we identified 150 individuals without diabetes and hypertension; in the second analysis of 260 individuals, we identified 44 individuals without diabetes, hypertension and hypertriglyceridemia. We used multivariable logistic regression to examine the association between each group and potential risk factors including age, sex, race, body mass index, and presence of liver disease on liver biopsy.

RESULTS

The prevalence of individuals without diabetes and hypertension was 28.7%; among these individuals 88.7% had liver steatosis, 7.3% nonalcoholic steatohepatitis (NASH), and 19.3% liver fibrosis. These individuals were significantly more likely to be white OR=1.9 (95% CI: 1.1-3.1), younger OR=4.1 (95% CI=2.6-6.3), and female OR=2.1, (95% CI=1.2-3.6) and less likely to have liver steatosis OR=0.4 (95% CI=0.2-0.9) or NASH OR=0.3 (95% CI=0.2-0.6).

CONCLUSION

Among bariatric surgery patients, almost a third of patients do not have diabetes and hypertension and could be probably considered "MHO" and were more likely to be white, young, female, and have less liver injury. The high prevalence of liver steatosis in MHO individuals among bariatric surgery patients challenges the notion of MHO as a truly metabolically healthy entity.

摘要

背景

最近的研究描述了一类独特的肥胖个体,尽管体重超标,但代谢状况正常,被称为“代谢健康的肥胖者(MHO)”。我们的目的是确定在接受减肥手术的患者中,无糖尿病和高血压的个体的患病率以及与MHO表型相关的危险因素。

方法

我们对2008年至2010年间在约翰霍普金斯医院接受减肥手术的710名成年人进行了一项回顾性研究。在对523名个体的首次分析中,我们确定了150名无糖尿病和高血压的个体;在对260名个体的第二次分析中,我们确定了44名无糖尿病、高血压和高甘油三酯血症的个体。我们使用多变量逻辑回归来检验每组与潜在危险因素之间的关联,这些危险因素包括年龄、性别、种族、体重指数以及肝活检时是否存在肝病。

结果

无糖尿病和高血压的个体的患病率为28.7%;在这些个体中,88.7%有肝脂肪变性,7.3%有非酒精性脂肪性肝炎(NASH),19.3%有肝纤维化。这些个体更有可能是白人(OR=1.9,95%CI:1.1 - 3.1)、更年轻(OR=4.1,9%CI=2.6 - 6.3)以及女性(OR=2.1,95%CI=1.2 - 3.6),并且患肝脂肪变性(OR=0.4,95%CI=0.2 - 0.9)或NASH(OR=0.3,95%CI=0.2 - 0.6)的可能性更小。

结论

在接受减肥手术的患者中,近三分之一的患者没有糖尿病和高血压,可能被视为“MHO”,并且更有可能是白人、年轻人、女性,且肝损伤较轻。减肥手术患者中MHO个体肝脂肪变性的高患病率对MHO作为真正代谢健康实体的观念提出了挑战。

相似文献

2
Prevalence of NASH/NAFLD in people with obesity who are currently classified as metabolically healthy.
Surg Obes Relat Dis. 2020 Dec;16(12):2050-2057. doi: 10.1016/j.soard.2020.07.009. Epub 2020 Jul 14.
3
Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery.
J Gastroenterol. 2016 Mar;51(3):281-9. doi: 10.1007/s00535-015-1114-8. Epub 2015 Aug 28.
4
Risk factors and prevalence of liver disease in review of 2557 routine liver biopsies performed during bariatric surgery.
Surg Obes Relat Dis. 2019 Jun;15(6):843-849. doi: 10.1016/j.soard.2019.01.035. Epub 2019 Mar 20.
5
Hepatic histology in obese patients undergoing bariatric surgery.
J Hepatol. 2006 Oct;45(4):600-6. doi: 10.1016/j.jhep.2006.06.013. Epub 2006 Jul 25.

引用本文的文献

1
Factors Associated With Semaglutide Initiation Among Adults With Obesity.
JAMA Netw Open. 2025 Jan 2;8(1):e2455222. doi: 10.1001/jamanetworkopen.2024.55222.
3
Gender Differences in Nonalcoholic Fatty Liver Disease.
Euroasian J Hepatogastroenterol. 2022 Jul;12(Suppl 1):S19-S25. doi: 10.5005/jp-journals-10018-1370.
4
Metabolically Healthy Obesity and Bariatric Surgery.
Obes Surg. 2019 Sep;29(9):2989-3000. doi: 10.1007/s11695-019-03964-8.

本文引用的文献

2
Metabolically-healthy obesity and coronary artery calcification.
J Am Coll Cardiol. 2014 Jun 24;63(24):2679-86. doi: 10.1016/j.jacc.2014.03.042. Epub 2014 Apr 30.
4
Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis.
Ann Intern Med. 2013 Dec 3;159(11):758-69. doi: 10.7326/0003-4819-159-11-201312030-00008.
5
Influence of ethnicity on the efficacy and utilization of bariatric surgery in the USA.
J Gastrointest Surg. 2014 Jan;18(1):130-6. doi: 10.1007/s11605-013-2368-1. Epub 2013 Oct 8.
6
All-cause mortality risk of metabolically healthy abdominal obese individuals: the EPIC-MORGEN study.
Obesity (Silver Spring). 2014 Feb;22(2):557-64. doi: 10.1002/oby.20480. Epub 2013 Jul 5.
8
Metabolic effects of bariatric surgery in insulin-sensitive morbidly obese subjects.
Obes Surg. 2013 Apr;23(4):494-500. doi: 10.1007/s11695-012-0817-7.
9
Differences in outcomes of laparoscopic gastric bypass.
Surg Obes Relat Dis. 2011 May-Jun;7(3):277-82. doi: 10.1016/j.soard.2011.02.005. Epub 2011 Feb 24.
10
Characterizing the profile of obese patients who are metabolically healthy.
Int J Obes (Lond). 2011 Jul;35(7):971-81. doi: 10.1038/ijo.2010.216. Epub 2010 Oct 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验